The Development of Novel Apurinic/Aprymidinic Endonuclease/Redox-factor 1 Inhibitors for the Treatment of Human Melanoma
Author(s) -
Bella Sharifi
Publication year - 2019
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.36837/chapman.000103
Subject(s) - ap site , dna (apurinic or apyrimidinic site) lyase , endonuclease , transcription factor , dna , dna repair , dna damage , ap endonuclease , cancer research , biology , chemistry , microbiology and biotechnology , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom